Nyxoah SA

The momentum for this stock is not very good. Nyxoah SA is not a good value stock. Nyxoah SA is not a good growth stock. Tradey thinks it is not wise to invest in Nyxoah SA.

News

Nyxoah to Participate in Upcoming Investor Conferences

Globe Newswire Nyxoah to Participate in Upcoming Investor Conferences Mont-Saint-Guibert, Belgium September 5, 2024, 10:30pm CET / 4:30pm ET Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) ( Nyxoah or the Company...\n more…

Nyxoah Gears Up for US Genio System Launch

TipRanks Financial Blog Nyxoah (NYXH) has released an update. Nyxoah celebrated its clinical and regulatory milestones by ringing the closing bell on Nasdaq, marking progress towards the A...\n more…

Nyxoah Rings the Closing Bell at Nasdaq while Preparing for U.S. Market Launch of Innovative Sleep Apnea Device

Globe Newswire Nyxoah Rings the Closing Bell at Nasdaq while Preparing for U.S. Market Launch of Innovative Sleep Apnea Device FDA regulatory submission for the Company's Genio device is complete, U.S...\n more…

Research Analysts Set Expectations for Nyxoah S.A.'s Q3 2024 Earnings (NASDAQ:NYXH)

Zolmax Nyxoah S.A. (NASDAQ:NYXH - Free Report) - Stock analysts at HC Wainwright increased their Q3 2024 earnings per share (EPS) estimates for shares of Nyxoah in a note issued to investors on...\n more…

FY2024 Earnings Estimate for Nyxoah S.A. (NASDAQ:NYXH) Issued By Cantor Fitzgerald

Ticker Report Nyxoah S.A. (NASDAQ:NYXH - Free Report) - Analysts at Cantor Fitzgerald decreased their FY2024 EPS estimates for Nyxoah in a research note issued on Wednesday, August 7th. Cantor Fitzgerald analyst...\n more…

Oppenheimer Lowers Nyxoah (NASDAQ:NYXH) Price Target to $13.00

Zolmax Nyxoah (NASDAQ:NYXH - Get Free Report) had its target price reduced by research analysts at Oppenheimer from $15.00 to $13.00 in a research report issued to clients and investors on Wednesday...\n more…